Home › Research › Topics › amyloid-reduction
amyloid-reduction
3 studies tagged amyloid-reduction, dated 2009-06-01 to 2026-09-21. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Blood Amyloid-β Reduction Following Chongnoi-tang Treatment in Alzheimer's Spectrum Conditions: A Retrospective Pilot Observational Study 2026-09-21
- Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice 2014-08-01
- Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease 2009-06-01
Studies
3 studies carry this tag.
Date range
2009 to 2026
Top journals
- The Journal of neuroscience : the official journal of the Society for Neuroscience 2
- Journal of clinical medicine 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
In this small, uncontrolled pilot study, CNT was associated with blood Aβ reductions, which should be interpreted as a statistical association rather than confirmed evidence of a treatment effect; no treatment discontinuations due to adverse effects were documented in this small cohort, including among APOE ε4/ε4 carriers.
-
Therapeutic approaches for prevention or reduction of amyloidosis are currently a main objective in basic and clinical research on Alzheimer's disease.
-
Shown to lower amyloid deposits and improve cognition in APP transgenic mouse models, immunotherapy appears to be a promising approach for the treatment of Alzheimer's disease (AD).